Clinical Trials Corner: Raising the SABR to Renal Cell Carcinoma

Clinical Trials Corner

Bladder-sparing strategies are actively sought by patients looking to preserve their quality of life. Urologists are softening to this approaches while radiation oncologists are becoming more precise in their treatment with fewer side effects. This month’s issue of the Clinical Trials Corner of the Bladder Cancer Journal is devoted towards two actively recruiting radiation trials that hope to c...

Clinical Trials Corner

Welcome to the fi rst edition of the Clinical Trials Corner of Nutrition and Healthy Aging. The aim of this section is to inform readers of upcoming clinical trials and highlight new fi ndings. If you would like to draw attention to a specifi c topic and clinical trials, please email me at: [email protected] Interest in nicotinamide riboside (NR), a putative anti-aging nutritiona...

Clinical Trials Corner: September 2017

Clinical Trials Corner of Journal of Huntington's Disease will regularly review ongoing and recently completed clinical trials in Huntington's disease. In this inaugural issue, we list all currently registered and ongoing clinical trials, expand on LEGATO-HD and IONIS-HTTRx, and cover two recently finished trials: Amaryllis and Pride-HD.

Dyspnea as the First Manifestation of Silent Renal Cell Carcinoma

Renal cell carcinoma (RCC) accounts for only 3% of adult malignancies, and the lung is the most common site of metastasis of this tumor, which may be accompanied by pleural metastasis. However, solitary pleural involvement is very rare and its presentation with dyspnea as the first manifestation of RCC is extremely rare.We describe a 39-year-old male with episodes of dyspnea dating back 6...

Sarcomatoid Transrormation of Chromophobe Renal Cell Carcinoma